Search research articles
Contact Us
Filters
Showing results (31-40 of 47) with videos related to
Page
of 5
Sort By:
The EMBO Journal
|
July 16, 1997
The solution NMR structure of glucosylated N-glycans involved in the early stages of glycoprotein biosynthesis and folding
A J Petrescu, T D Butters, G Reinkensmeier, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 15, 1994
Secretion of human hepatitis B virus is inhibited by the imino sugar N-butyldeoxynojirimycin
T M Block, X Lu, F M Platt, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 26, 1999
Delayed symptom onset and increased life expectancy in Sandhoff disease mice treated with N-butyldeoxynojirimycin
M Jeyakumar, T D Butters, M Cortina-Borja, et al.
Analytical Biochemistry
|
November 10, 2001
High-performance liquid chromatography analysis of ganglioside carbohydrates at the picomole level after ceramide glycanase digestion and fluorescent labeling with 2-aminobenzamide
D R Wing, B Garner, V Hunnam, et al.
The Journal of Biological Chemistry
|
March 14, 2000
Mutations at critical N-glycosylation sites reduce tyrosinase activity by altering folding and quality control
N Branza-Nichita, G Negroiu, A J Petrescu, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 16, 1999
Imino sugars inhibit the formation and secretion of bovine viral diarrhea virus, a pestivirus model of hepatitis C virus: implications for the development of broad spectrum anti-hepatitis virus agents
N Zitzmann, A S Mehta, S Carrouée, et al.
Nature Communications
|
September 21, 2019
NPC1 regulates ER contacts with endocytic organelles to mediate cholesterol egress
D Höglinger, T Burgoyne, E Sanchez-Heras, et al.
Journal of Virology
|
September 1, 1995
The alpha-glucosidase inhibitor N-butyldeoxynojirimycin inhibits human immunodeficiency virus entry at the level of post-CD4 binding
P B Fischer, M Collin, G B Karlsson, et al.
Blood
|
January 3, 2001
Enhanced survival in Sandhoff disease mice receiving a combination of substrate deprivation therapy and bone marrow transplantation
M Jeyakumar, F Norflus, C J Tifft, et al.
Science (New York, N.Y.)
|
April 18, 1997
Prevention of lysosomal storage in Tay-Sachs mice treated with N-butyldeoxynojirimycin
F M Platt, G R Neises, G Reinkensmeier, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 47) with videos related to
Sort By:
Page
of 5
The EMBO Journal
|
July 16, 1997
The solution NMR structure of glucosylated N-glycans involved in the early stages of glycoprotein biosynthesis and folding
A J Petrescu, T D Butters, G Reinkensmeier, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 15, 1994
Secretion of human hepatitis B virus is inhibited by the imino sugar N-butyldeoxynojirimycin
T M Block, X Lu, F M Platt, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 26, 1999
Delayed symptom onset and increased life expectancy in Sandhoff disease mice treated with N-butyldeoxynojirimycin
M Jeyakumar, T D Butters, M Cortina-Borja, et al.
Analytical Biochemistry
|
November 10, 2001
High-performance liquid chromatography analysis of ganglioside carbohydrates at the picomole level after ceramide glycanase digestion and fluorescent labeling with 2-aminobenzamide
D R Wing, B Garner, V Hunnam, et al.
The Journal of Biological Chemistry
|
March 14, 2000
Mutations at critical N-glycosylation sites reduce tyrosinase activity by altering folding and quality control
N Branza-Nichita, G Negroiu, A J Petrescu, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 16, 1999
Imino sugars inhibit the formation and secretion of bovine viral diarrhea virus, a pestivirus model of hepatitis C virus: implications for the development of broad spectrum anti-hepatitis virus agents
N Zitzmann, A S Mehta, S Carrouée, et al.
Nature Communications
|
September 21, 2019
NPC1 regulates ER contacts with endocytic organelles to mediate cholesterol egress
D Höglinger, T Burgoyne, E Sanchez-Heras, et al.
Journal of Virology
|
September 1, 1995
The alpha-glucosidase inhibitor N-butyldeoxynojirimycin inhibits human immunodeficiency virus entry at the level of post-CD4 binding
P B Fischer, M Collin, G B Karlsson, et al.
Blood
|
January 3, 2001
Enhanced survival in Sandhoff disease mice receiving a combination of substrate deprivation therapy and bone marrow transplantation
M Jeyakumar, F Norflus, C J Tifft, et al.
Science (New York, N.Y.)
|
April 18, 1997
Prevention of lysosomal storage in Tay-Sachs mice treated with N-butyldeoxynojirimycin
F M Platt, G R Neises, G Reinkensmeier, et al.
Page
of 5